Series B funding will strengthen Multiply Labs' momentum scaling the robotic manufacturing platform turning AI-discovered drugs into treatments patients can receive.

Multiply Labs Inc., a startup that develops automation equipment for drugmakers, has raised $75 million in funding.

SAN FRANCISCO--(BUSINESS WIRE)--Multiply Labs, a leader in robotic biomanufacturing, today announced a landmark milestone in its mission to scale production of cell and gene therapies; The company is ...

Multiply today announced the launch of its Ad Spend Recovery Agent, an AI agent built to help marketers identify and eliminate wasted advertising spend that is difficult to catch through manual ...

Multiply Labs has stayed busy in 2024. After expanding its collaboration with Thermo Fisher in February, the company also inked new partnerships with the likes of Akron Bio, Wilson Wolf and GenScript.

San Francisco, CA, March 18, 2026 (GLOBE NEWSWIRE)-- Multiply is the first AI-native media agency for B2B companies. All marketers know that in traditional advertising, campaigns start losing ...